Analysis reveals strategies for managing nitrosamine impurities in pharmaceuticals, indicating important safety measures.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Balaji Nagarajan (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: